Combination GLP-1 and Insulin Treatment Fails to Alter Myocardial Fuel Selection Versus Insulin Alone in Type 2 Diabetes.

Conclusions: These observations argue against large effects of GLP-1 agonists on myocardial fuel metabolism as mediators of beneficial treatment effects on myocardial function and ischemia protection. PMID: 30020461 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30020461?dopt=Abstract

Source: The Journal of Clinical Endocrinology and Metabolism - July 17, 2018 Category: Endocrinology Authors: Mather KJ, Considine RV, Hamilton L, Patel NA, Mathias C, Territo W, Goodwill A, Tune JD, Green MA, Hutchins GD Tags: J Clin Endocrinol Metab Source Type: research